HEALTHglobal
Sudden Sight Loss Risk Almost 5x Higher With Wegovy Than Ozempic, Study Finds - ScienceAlert
Single source
Updated 2 hours ago
First seen March 16, 2026 23:18:52Stay on top of this story
Follow the names and topics behind it.
Add this story's key topics to your watchlist so LyscoNews can highlight related developments and future matches.
Create a free account to sync your watchlist, saved stories, and alerts across devices.
Quick Summary
Sudden Sight Loss Risk Almost 5x Higher With Wegovy Than Ozempic, Study Finds ScienceAlert Wegovy users have five times greater risk of sudden sight loss than Ozempic users, study finds The Guardian Wegovy users may have 5 times risk of vision loss than those on Ozempic Medical News Today Wegovy May Carry Highest Risk of Blinding Condition Among GLP-1 Drugs MedPage Today Study Looks at Associations Between Semaglutide and Ischemic Optic Neuropathy Optometry Advisor